Whittier Trust’s Armata Pharmaceuticals ARMP Stock Holding History

Whittier Trust’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05K	Hold	100	–	–	﹤0.01%	1300
2025 Q4	$587	Buy	+100	New	+$548	﹤0.01%	1330

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Whittier Trust's ARMP Position: Q1 2026 in Review

Whittier Trust held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 100 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Whittier Trust first reported a position in ARMP in Q4 2025 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

Whittier Trust held 100 shares of Armata Pharmaceuticals worth $1.05K as of Q1 2026.
Whittier Trust left its Armata Pharmaceuticals share count unchanged in Q1 2026.
Armata Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q1 2026, its #1300 holding.
Whittier Trust first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.